Thus both HGF and myoblast sheet therapy harbor proangiogenic potential in the ischemic myocardium [9], [11] and could provide a synergistic therapeutic effect even in the difficult-to-treat setting of chronic heart failure. Here, HGF is linked to congestive heart failure.